Cambrex is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.
Cambrex is a publicly traded company on NYQ using the ticker symbol CBM.
Detailed information on company financials and operating reports can be found here:
NYQ: CBM
Note: Cambrex's revenues are gauged from an analysis of company filings.
Market Share of Cambrex's Largest Competitors
A competitive analysis shows these companies are in the same general field as Cambrex, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Cambrex.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Cambrex and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.